MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

Barbara Oldrini(Spanish National Cancer Research Centre), Massimo Squatrito(AstraZeneca (United Kingdom))

Nature Communications

August 4, 2020

10.1038/s41467-020-17717-0

Cited by 195

Related Papers

Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4

|Nature|2022|88

Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling

|Nature Communications|2018|73

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1

|bioRxiv (Cold Spring Harbor Laboratory)|2019|9

Somatic genome editing with the RCAS/TVA-CRISPR/Cas9 system for precision tumor modeling

|bioRxiv (Cold Spring Harbor Laboratory)|2017|6